Blog

Tag: CMC

NEWS

A Milestone for Gene Therapy

NANJING, China, May 28, 2026 — Yaohai Bio-Pharma congratulates its strategic partner, Beijing Northland Biotechnology Co., Ltd. (“Northland Bio”), on the NMPA approval of Donaperminogene

June 1, 2026 No Comments

NEWS

Yaohai’s CRDMO is the New Trend

Yaohai Bio-Pharma has once again been recognized as a leading innovator in the global biopharmaceutical industry. During the 2026 Future Healthcare 100 Conference held on

May 21, 2026 No Comments

Yaohai Bio-Pharma upholds a philosophy of dedication and collaboration, driving drug innovation and healthier lives.

Company

CRDMO

solutions

